Trastuzumab Cardiotoxicity
1 clinical trials · Condition
◉ Watch Trastuzumab Cardiotoxicity
| Record | Firm | Date |
|---|---|---|
| Assessment for Long-Term Cardiovascular Impairment Associated With Trastuzumab Cardiotoxicity in HER2-Positive Breast Cancer Survivors (NCT02615054) | Memorial Sloan Kettering Cancer Center | 2015-11-18 |
Track Trastuzumab Cardiotoxicity automatically
Every clearance here is in the API, with alerts when new ones post.